A review on newly approved PARP inhibitors: Talazoparib and Olaparib

समान संसाधन

• A review on potential of PARP inhibitors in the treatment of prostate cancer
  द्वारा: Islam, Saidul
  प्रकाशित: (2022)
• Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
  द्वारा: Ahmed, Nafisa
  प्रकाशित: (2023)
• SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
  द्वारा: Meem, Manila
  प्रकाशित: (2023)
• Mutation in DNA polymerase γ: mitochondrial disorders
  द्वारा: Hossain, Sadman Sanjid
  प्रकाशित: (2023)
• RIPK pathway, as a potential target, for cancer treatment - a review
  द्वारा: Jahan, Nusrat
  प्रकाशित: (2024)